Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

30.82 -1.79 (-5.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Levi Strauss, Tilray Brands And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Got $2,000? Consider Buying These 2 Beaten-Down Cathie Wood Stocks at Your Own Risk
Their long-term plans are ambitious, but they haven't performed well as investments recently. 
Via The Motley Fool
Where Twist Bioscience Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Twist Bioscience (NASDAQ:TWST) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Twist Bioscience to Present at JSNN NanoImpacts 2022
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Q3 Sales Jump 60%, Raises FY22 Revenue Outlook Surpassing Consensus
Via Benzinga
Recap: Twist Bioscience Q3 Earnings
  Twist Bioscience (NASDAQ:TWST) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls For Developing Assays
Via Benzinga
Twist Bioscience to Present at Baird 2022 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Catalent, Tellurian And Other Big Losers From Monday
U.S. stocks closed lower with the Dow Jones dropping around 185 points on Monday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Block To $130? Plus Oppenheimer Predicts $11 For GoPro
Oppenheimer cut the price target for GoPro, Inc. (NASDAQ: GPRO) from $12 to $11. GoPro shares rose 1.2% to $6.64 in pre-market trading. 
Via Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Gainers 
Via Benzinga
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Earnings Scheduled For August 5, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. 
Via Benzinga
Twist Bioscience Earnings Preview
Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Twist... 
Via Benzinga
Twist Bioscience to Present at Flash Memory Summit
From Twist Bioscience Corporation
Via Business Wire
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
5 Top Stocks Cathie Wood Bought This Week
Shares of ARKK are up about 20% the past month as Cathie Wood continues her highly-convicted purchases of growth stocks. 
Via InvestorPlace
Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
From Twist Bioscience Corporation
Via Business Wire
DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow
From DNAnexus, Inc.
Via Business Wire
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.